Science for a better life
Effect of Finerenone* on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Thank you for your interest in the results of FIDELIO-DKD. The peer-reviewed publication of FIDELIO-DKD is now available in the New England Journal of Medicine. To access it click here.
For your convenience, you can download the presented slides in the language of your choice below.
For more information regarding Finerenone* please visit us by clicking on the button below
*The compound presented is being investigated for use and has not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.